Plus Therapeutics Statistics Share Statistics Plus Therapeutics has 60.49M
shares outstanding. The number of shares has increased by 764.92%
in one year.
Shares Outstanding 60.49M Shares Change (YoY) 764.92% Shares Change (QoQ) 332.74% Owned by Institutions (%) 6.6% Shares Floating 60.31M Failed to Deliver (FTD) Shares 161,219 FTD / Avg. Volume 0.51%
Short Selling Information The latest short interest is 3.74M, so 7.33% of the outstanding
shares have been sold short.
Short Interest 3.74M Short % of Shares Out 7.33% Short % of Float 7.35% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.59 and the forward
PE ratio is -1.86.
Plus Therapeutics's PEG ratio is
0.01.
PE Ratio -0.59 Forward PE -1.86 PS Ratio 1.31 Forward PS 6.3 PB Ratio -0.85 P/FCF Ratio -0.68 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Plus Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.34,
with a Debt / Equity ratio of -0.38.
Current Ratio 0.34 Quick Ratio 0.34 Debt / Equity -0.38 Debt / EBITDA -0.4 Debt / FCF -0.3 Interest Coverage -3.95
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $277.33K Profits Per Employee $-618K Employee Count 21 Asset Turnover 0.88 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -50.35% in the
last 52 weeks. The beta is 0.67, so Plus Therapeutics's
price volatility has been higher than the market average.
Beta 0.67 52-Week Price Change -50.35% 50-Day Moving Average 0.4 200-Day Moving Average 0.88 Relative Strength Index (RSI) 69.5 Average Volume (20 Days) 31,385,737
Income Statement In the last 12 months, Plus Therapeutics had revenue of 5.82M
and earned -12.98M
in profits. Earnings per share was -1.95.
Revenue 5.82M Gross Profit 4.97M Operating Income -14.7M Net Income -12.98M EBITDA -8.4M EBIT -9.25M Earnings Per Share (EPS) -1.95
Full Income Statement Balance Sheet The company has 76K in cash and 3.37M in
debt, giving a net cash position of -3.29M.
Cash & Cash Equivalents 76K Total Debt 3.37M Net Cash -3.29M Retained Earnings -493.48M Total Assets 12.06M Working Capital -135K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.55M
and capital expenditures -146K, giving a free cash flow of -11.24M.
Operating Cash Flow -10.55M Capital Expenditures -146K Free Cash Flow -11.24M FCF Per Share -1.69
Full Cash Flow Statement Margins Gross margin is 85.37%, with operating and profit margins of -252.32% and -222.84%.
Gross Margin 85.37% Operating Margin -252.32% Pretax Margin -222.84% Profit Margin -222.84% EBITDA Margin -144.27% EBIT Margin -252.32% FCF Margin -193.08%
Dividends & Yields PSTV does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PSTV is $9,
which is 1185.7% higher than the current price. The consensus rating is "Buy".
Price Target $9 Price Target Difference 1185.7% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 1, 2023. It was a
backward
split with a ratio of 1:15.
Last Split Date May 1, 2023 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -63.72 Piotroski F-Score 2
